Graham Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $586K | Sell |
125,417
-8,251
| -6% | -$38.5K | 0.01% | 718 |
|
|
2025
Q1 | $734K | Buy |
133,668
+63,006
| +89% | +$346K | 0.01% | 624 |
|
|
2024
Q4 | $240K | Buy |
70,662
+17,209
| +32% | +$58.3K | ﹤0.01% | 992 |
|
|
2024
Q3 | $152K | Sell |
53,453
-1,688
| -3% | -$4.81K | ﹤0.01% | 934 |
|
|
2024
Q2 | $124K | Sell |
55,141
-31,478
| -36% | -$70.8K | ﹤0.01% | 892 |
|
|
2024
Q1 | $191K | Buy |
86,619
+49,835
| +135% | +$110K | ﹤0.01% | 882 |
|
|
2023
Q4 | $86.4K | Sell |
36,784
-20,625
| -36% | -$48.5K | ﹤0.01% | 891 |
|
|
2023
Q3 | $107K | Buy |
+57,409
| New | +$107K | ﹤0.01% | 918 |
|